Trust Signals
- Written by the FormBlends Medical Team, cross-referenced against Eli Lilly prescribing information, USP 797 (2023 revision), and FDA guidance on compounded GLP-1 medications.
- No affiliate relationships with any compounding pharmacy or tirzepatide supplier.
- Every storage claim is sourced to a named document. Where manufacturer data does not exist for compounded forms, USP standards are cited and labeled as such.
- Last reviewed and updated: 2026-05-29.
Key Takeaways
- FDA-approved Mounjaro and Zepbound single-dose pens are stable refrigerated at 2 to 8 degrees C until the printed expiration date, and usable at room temperature (up to 30 degrees C) for a maximum of 21 days after removal.
- Compounded multi-dose vials typically carry a 28-day beyond-use date after first puncture under USP 797 Category 2 standards; unopened vials may be assigned up to 90 days, but this varies by pharmacy and formulation.
- Freezing destroys tirzepatide. Ice crystal formation disrupts the peptide's three-dimensional structure and cannot be reversed by thawing.
- Visual inspection catches aggregation and gross contamination but cannot detect early-stage chemical degradation. Date-tracking is essential regardless of appearance.
- Semaglutide pens allow 56 days at room temperature after first use versus 21 days for tirzepatide, a formulation difference that matters for travelers.
How Long Will Tirzepatide Last in the Fridge? (Direct Answer)
FDA-approved tirzepatide pens (Mounjaro, Zepbound) remain stable refrigerated at 2 to 8 degrees C until the printed expiry. Compounded multi-dose vials are typically dated 28 days post-puncture or up to 90 days unopened, per USP 797 and pharmacy-specific stability data. Never freeze. Once at room temperature, discard pens after 21 days.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
What Are the Exact Storage Windows for Each Product Format?
| Format | Refrigerated (2 to 8 C) | Room Temp (up to 30 C) | After First Use / Puncture | Source |
|---|---|---|---|---|
| Mounjaro / Zepbound single-dose pen | Until printed expiry | Up to 21 days, then discard | Single-dose; discard after use | Eli Lilly prescribing information |
| Compounded multi-dose vial (sterile, USP 797 Cat. 2) | Up to 90 days unopened (pharmacy-assigned BUD) | Generally not recommended beyond brief excursion | 28 days from first puncture (USP 797 default) | USP 797 (2023), pharmacy stability data |
| Reconstituted lyophilized tirzepatide (research grade) | Typically 30 to 90 days per supplier SDS | Not recommended | Varies; often 30 days post-reconstitution | Supplier SDS (variable, not FDA-reviewed) |
Why Does Tirzepatide Need Refrigeration? The Chemistry with Specific Numbers
Tirzepatide is a 39-amino-acid synthetic dual incretin agonist. Its structure includes a C18 fatty diacid chain attached via a linker at lysine-26, a modification borrowed from the semaglutide design approach that extends half-life to roughly 5 days in vivo by promoting albumin binding. That fatty-acid modification, while clinically useful, also introduces a hydrophobic surface that facilitates aggregation at elevated temperatures.
Three degradation pathways become relevant outside cold storage:
- Hydrolysis. Water molecules attack peptide bonds, cleaving the amino-acid chain into inactive fragments. Hydrolysis rate increases roughly 2-fold to 3-fold for every 10-degree-C rise in temperature (Q10 rule), meaning a vial at 37 degrees C degrades meaningfully faster than one at 8 degrees C. This is the primary chemical driver behind the 21-day room-temperature limit.
- Oxidation. Methionine and tryptophan residues (if present in the sequence context) are susceptible to oxidative modification. Oxygen ingress after vial puncture accelerates this pathway, which is one reason the post-puncture BUD is shorter than the sealed-vial expiry.
- Aggregation. The hydrophobic fatty-acid chain promotes self-association at higher temperatures. Aggregates are not only inactive but potentially immunogenic, a clinically meaningful concern for a drug given weekly over months to years.
Refrigeration at 2 to 8 degrees C slows all three pathways by reducing molecular kinetic energy, limiting water activity at the peptide surface, and reducing dissolved oxygen mobility. The 30-degree-C upper limit for the 21-day room-temperature window is not arbitrary: it is the threshold at which Eli Lilly's accelerated stability studies demonstrated acceptable degradation product accumulation within that time window.
What Happens If Tirzepatide Is Frozen or Gets Too Warm?
Freezing (below 0 degrees C): Ice crystal nucleation around and within the peptide disrupts hydrogen bonding and tertiary structure. Upon thawing, aggregates form that do not redissolve. The Eli Lilly prescribing information for both Mounjaro and Zepbound states explicitly: do not freeze. This applies to both the pen body and the reservoir cartridge. Discard any product that has frozen, even if it appears clear after thawing, because aggregation can be sub-visual.
Excursion above 30 degrees C: For FDA-approved pens, any excursion above 30 degrees C or any room-temperature storage exceeding 21 days total triggers a discard recommendation. There is no validated recovery protocol for overheated tirzepatide pens. For compounded vials, the excursion tolerance is less formally defined in public manufacturer documents; the conservative and correct approach is to contact the dispensing pharmacy with the specific excursion details (temperature reached, duration) and follow their guidance.
Evidence Ledger: How Confident Should You Be in These Storage Claims?
| Claim | Best Evidence Type | Effect Direction | Confidence |
|---|---|---|---|
| Mounjaro/Zepbound pen: refrigerated until expiry, room temp 21 days max | Manufacturer accelerated stability studies (ICH Q1A guideline), FDA-reviewed label | Established limit | High |
| Do not freeze; freezing causes irreversible aggregation | General peptide physical chemistry; manufacturer label warning | Harm direction confirmed | High |
| Compounded vial: 28-day post-puncture BUD | USP 797 (2023) regulatory standard; not product-specific stability data | Conservative contamination limit | Moderate (regulatory standard, not clinical trial) |
| Hydrolysis rate doubles per 10-degree-C increase | Physical chemistry principle (Q10 rule); applied to peptides broadly | Mechanistic, directional | Moderate (mechanism well established; tirzepatide-specific Q10 not publicly published) |
| Sub-visual aggregates may be immunogenic | Class-level data for protein/peptide biologics; not tirzepatide-specific | Plausible concern | Low (mechanism extrapolated, no tirzepatide immunogenicity data from degraded product) |
| Compounded vial: up to 90 days unopened | Pharmacy-assigned BUD per USP 797 Category 2; varies by formulation | Provisional limit | Low to Moderate (pharmacy-specific; no universal published stability study) |
What Most Pages Get Wrong About Tirzepatide Refrigerator Life
Nearly every blog treating this topic makes one or more of the following errors:
- Conflating the pen format with the compounded vial format. The 21-day room-temperature rule applies to the FDA-approved single-dose pen. Compounded multi-dose vials do not automatically inherit that same window. They may have shorter or different BUDs based on sterility, not just chemical stability.
- Treating the expiry date as a stability guarantee regardless of handling. The printed expiry is valid only if the product has been stored continuously under label conditions. Any unrecorded temperature excursion, freeze event, or post-puncture time that exceeded the BUD invalidates that date.
- Omitting the difference between chemical degradation and microbial contamination. The 28-day post-puncture BUD for compounded vials is primarily a microbial safety limit under USP 797, not a reflection of how fast tirzepatide the molecule breaks down. The peptide may remain chemically intact past 28 days; the sterility concern is what drives the cutoff.
- Claiming visual clarity proves potency. Early hydrolysis and oxidation are chemically silent. A clear, colorless vial at day 45 post-puncture may have accumulated meaningful degradation products that no human eye can detect.
How to Tell If Refrigerated Tirzepatide Has Gone Bad
Inspect before every dose under good lighting against a white and then a dark background:
- Discard if: visible particles are present, the solution is cloudy or turbid, there is discoloration beyond a faint yellow (brown, orange, or pink tints suggest oxidative degradation).
- Discard if: the vial or pen has been frozen (even if now thawed and visually clear).
- Discard if: the post-puncture date or room-temperature window has been exceeded, regardless of appearance.
- Cannot rely on appearance to confirm: early chemical degradation, sub-visual aggregation, or microbial contamination below visible turbidity thresholds.
Honest Head-to-Head: Tirzepatide vs. Semaglutide Storage
| Parameter | Tirzepatide (Mounjaro/Zepbound pen) | Semaglutide (Ozempic pen) | Winner |
|---|---|---|---|
| Refrigerated storage | 2 to 8 C until expiry | 2 to 8 C until expiry | Tie |
| Room-temp window after first use | 21 days at up to 30 C | 56 days at up to 30 C (Ozempic label) | Semaglutide (for travel flexibility) |
| Freeze tolerance | None; discard if frozen | None; discard if frozen | Tie (both fail) |
| Single-dose format eliminates post-puncture contamination risk | Yes (pen is single-dose) | No (Ozempic pen is multi-dose cartridge) | Tirzepatide pen (simpler sterility profile) |
| Clinical weight-loss efficacy at comparable doses | Mean 20.9% body weight loss at highest dose (SURMOUNT-1, Jastreboff et al., NEJM 2022) | Mean 14.9% at 2.4 mg (STEP 1, Wilding et al., NEJM 2021) | Tirzepatide (on current trial data) |
Concession: The semaglutide pen's 56-day room-temperature window is a real practical advantage for frequent travelers who cannot guarantee refrigeration. If cold-chain reliability is a concern, this difference is clinically meaningful.
Operational Guide: Reading a COA and Beyond-Use Date Label
For compounded tirzepatide vials, the certificate of analysis (COA) and vial label together tell you whether the product is worth using. Here is what to look for:
On the COA:
- Identity test: HPLC retention time match or, better, mass spectrometry confirming the correct molecular mass (tirzepatide: approximately 4,813 Daltons). A COA showing only HPLC purity without identity confirmation is incomplete.
- Purity: Greater than 98% by HPLC is the standard for injectable peptides. Values below 95% are a red flag.
- Endotoxin: LAL (limulus amebocyte lysate) test result, limit less than 5 EU/kg/hr for general injectables per USP 85. Many compounding COAs express this as EU/mL; check whether the pharmacy has done the body-weight conversion.
- Sterility: USP 71 sterility test or sterility assurance through validated aseptic processing and environmental monitoring records.
- pH: Peptide injectables are typically formulated at pH 6.0 to 7.5. Values outside this range can accelerate degradation.
On the vial label:
- BUD (beyond-use date) must be present as a specific date, not just "use within 28 days," because the clock starts at a defined compounding date.
- Storage condition must match your fridge capability: "Store at 2 to 8 C, do not freeze" requires a refrigerator that does not freeze shelves near the back wall or freezer compartment.
- Concentration in mg/mL and total vial volume: cross-check against your dose to ensure you are drawing correctly. A 5 mg/mL vial requires a different draw volume than a 2.5 mg/mL vial for the same dose.
Can Tirzepatide Travel? Coolers, Flights, and Cold-Chain Breaks
Tirzepatide can travel, but the 21-day room-temperature limit and freeze prohibition require planning.
- Flights: Store in carry-on luggage, never checked baggage. Cargo holds can reach sub-zero temperatures. TSA permits medication liquids in carry-on in quantities exceeding 100 mL when accompanied by a prescription label or letter.
- Travel coolers: Insulin-style gel-pack coolers (e.g., products maintaining 2 to 8 C for 24 to 72 hours) work well for short trips. Ensure gel packs are not in direct contact with the vial or pen; a foam or paper barrier prevents local freezing at the gel-pack surface.
- Hotel refrigerators: Mini-bar fridges can fluctuate or run colder than 2 C. If the fridge compartment frosts or freezes, do not store tirzepatide there. The middle shelf away from the back wall is typically safest.
- Logging excursions: If you are unsure whether an excursion occurred, note the maximum temperature reached and duration. For approved pens, the 21-day room-temperature total is cumulative; days spent at room temperature before travel count toward that total.
FAQ
How long will tirzepatide last in the fridge?
FDA-approved Mounjaro and Zepbound single-dose pens are stable refrigerated (2 to 8 degrees C) until the printed expiry, or at room temperature up to 21 days once removed. Compounded multi-dose vials typically carry a 28-day beyond-use date after first puncture, or up to 90 days unopened, per USP 797 and individual pharmacy dating.
What happens to tirzepatide if the fridge gets too warm?
Temperatures above 30 degrees C accelerate peptide bond hydrolysis and aggregation. The FDA-approved pen label allows up to 30 degrees C for 21 days; beyond that the product should be discarded. Brief excursions to 25 degrees C for under a few hours are generally considered low risk based on manufacturer excursion data, but compounded vials have less published excursion tolerance.
Can tirzepatide be frozen?
No. Freezing causes ice crystal formation that disrupts the peptide's tertiary structure and can cause aggregation. Eli Lilly explicitly states Mounjaro and Zepbound must not be frozen. Discard any vial or pen that has been frozen.
Does a compounded tirzepatide vial last longer than the brand-name pen?
Unopened, a compounded vial may carry a similar nominal expiry to an approved pen. Once punctured, the multi-dose vial is typically limited to 28 days by USP 797 beyond-use dating, which is more conservative than the brand pen's single-dose format. The pen has no puncture-related contamination risk.
How can I tell if refrigerated tirzepatide has gone bad?
Discard if you see visible particles, cloudiness, or discoloration. Tirzepatide solution should be clear to slightly yellow and particle-free. A color shift toward brown or orange suggests oxidative degradation. Note that subtle chemical degradation can occur before any visual change, so date-tracking matters even if the solution looks clear.
What is the room-temperature stability of tirzepatide?
Eli Lilly's label states Mounjaro and Zepbound pens may be kept at room temperature (up to 30 degrees C or 86 degrees F) for a maximum of 21 days, after which they must be discarded even if not fully used. Compounded vials generally follow USP guidance; specific room-temperature BUDs vary by pharmacy and formulation.
Why does tirzepatide need refrigeration at all?
Tirzepatide is a 39-amino-acid dual GIP/GLP-1 receptor agonist. At elevated temperatures, peptide bonds hydrolyze, disulfide-adjacent residues oxidize, and the fatty-acid chain attached at lysine 26 can facilitate aggregation. Cold temperatures slow all three processes by reducing molecular kinetic energy and water activity at the peptide surface.
Does tirzepatide degrade faster once the vial is punctured?
Yes. Each needle puncture introduces a small risk of microbial contamination and allows oxygen ingress through the stopper. USP 797 therefore assigns a 28-day beyond-use date for multi-dose compounded sterile preparations under most conditions, which is why compounded vials carry a shorter post-puncture window.
What should I look for on a compounded tirzepatide COA?
Look for identity confirmation by HPLC or mass spectrometry, purity greater than 98 percent, endotoxin testing (LAL method, limit less than 5 EU/kg/hr for injectable peptides), sterility test result, pH (typically 6.0 to 7.5 for peptide injectables), and the beyond-use date with storage condition. A COA lacking mass spec identity or endotoxin data is incomplete.
Can tirzepatide be stored in an insulin-style travel cooler?
Yes, provided the cooler maintains 2 to 8 degrees C and does not allow freezing contact with ice packs. Gel-pack coolers designed for insulin typically work well. Avoid direct contact between the vial or pen and a frozen gel pack; a paper or foam barrier prevents freeze damage to the outer surface and accidental local freezing.
Does tirzepatide lose potency gradually or all at once?
Potency loss is gradual and follows degradation kinetics, not a cliff. The drug remains largely active within labeled storage windows. Beyond those windows, degradation products accumulate progressively; some are inactive fragments and some may be mildly immunogenic. There is no reliable visual or at-home chemical test to quantify potency loss.
How does tirzepatide fridge stability compare to semaglutide?
FDA-approved semaglutide (Ozempic, Wegovy) shares a similar refrigerated storage requirement of 2 to 8 degrees C and allows 56 days at room temperature after first use for Ozempic pens, versus 21 days for tirzepatide pens. Both must not be frozen. Semaglutide's slightly longer room-temperature window reflects formulation differences, not greater inherent peptide stability.
Sources
- Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. Revised 2024. Available at: accessdata.fda.gov.
- Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. Revised 2024. Available at: accessdata.fda.gov.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216. SURMOUNT-1 trial.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002. STEP 1 trial.
- United States Pharmacopeia. USP 797: Pharmaceutical Compounding - Sterile Preparations. 2023 revision. USP-NF.
- United States Pharmacopeia. USP 85: Bacterial Endotoxins Test. Current edition. USP-NF.
- United States Pharmacopeia. USP 71: Sterility Tests. Current edition. USP-NF.
- International Council for Harmonisation. ICH Q1A(R2): Stability Testing of New Drug Substances and Products. 2003.
- Novo Nordisk. Ozempic (semaglutide) Prescribing Information. Revised 2024. Available at: accessdata.fda.gov.
- FDA. Compounded Drug Products That Are Essentially a Copy of a Commercially Available Drug Product Under Section 503B. Guidance for Industry. 2018.
- Hawe A, Wiggenhorn M, van de Weert M, Garber JJ, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. Journal of Pharmaceutical Sciences. 2012;101(3):895-913.